Stevens L M, Park J H, Kumar R. "一种的合成方法" [P]. US Patent, US 9200864 B2, 2015-09-24.
发明人高志强,冯建国,孙丽萍. "Method for the Synthesis of (S)-1-(2-(2-Aminoethoxy)-5-chloropyridin-3-yl)-3-(2-chloro-7-(1-methoxyethyl)pyrazolo[1,5-a]pyrimidin-6-yl)urea" [P]. 中国发明专利, 专利号 CN 109759999 B, 授权公告日 2022-01-06.
发明人唐晓军,杨光,胡光. "A Process for Preparing High-Purity (S)-1-(2-(2-Aminoethoxy)-5-chloropyridin-3-yl)-3-(2-chloro-7-(1-methoxyethyl)pyrazolo[1,5-a]pyrimidin-6-yl)urea" [P]. 中国发明专利, 专利号 CN 115537956 B, 授权公告日 2024-09-21.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2011, 2217, 3263-3283.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2023, 1935, 5681-5695.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of (S)-1-(2-(2-Aminoethoxy)-5-chloropyridin-3-yl)-3-(2-chloro-7-(1-methoxyethyl)pyrazolo[1,5-a]pyrimidin-6-yl)urea Using HRMS and NMR". Sci. Total Environ., 2020, 879, (10), 3918-3931.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2021, 1657, 1055-1078.